Compound ID | 2
FY-901
Class: Aminoglycoside
| Agent Type: | Natural product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Institute where first reported: | Changzhou Fangyuan Pharmaceutical, China |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790266/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.